Aqr Capital Management LLC Adverum Biotechnologies, Inc. Transaction History

Aqr Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $199,738 - $309,745	-21,570 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $435,990 - $631,832	-44,308 Reduced 67.26%	21,570 $234,000
Q3 2020 Nov 16, 2020	SELL	$10.3 - $21.64 $241,452 - $507,284	-23,442 Reduced 26.24%	65,878 $679,000
Q2 2020 Aug 17, 2020	SELL	$8.53 - $25.64 $751,561 - $2.26 Million	-88,108 Reduced 49.66%	89,320 $1.87 Million
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $1.11 Million - $2.26 Million	138,762 Added 358.87%	177,428 $1.73 Million
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $48,880 - $116,664	9,547 Added 32.79%	38,666 $445,000
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $25,455 - $77,193	4,858 Added 20.02%	29,119 $159,000
Q2 2019 Aug 14, 2019	SELL	$5.1 - $11.89 $52,682 - $122,823	-10,330 Reduced 29.86%	24,261 $288,000
Q1 2019 May 14, 2019	SELL	$3.03 - $6.02 $129,668 - $257,625	-42,795 Reduced 55.3%	34,591 $181,000
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $177,056 - $365,216	-61,692 Reduced 44.36%	77,386 $244,000
Q3 2018 Nov 15, 2018	BUY	$4.5 - $7.6 $469,377 - $792,725	104,306 Added 299.97%	139,078 $841,000
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $184,291 - $239,926	34,772 New	34,772 $184,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $522M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.